Arcutis Biotherapeutics CEO Todd Watanabe sells $74,892 in stock
ORIGINAL SOURCE →via Investing.com
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] Ondo completes first cross-border, cross-bank redemption of tokenised US treasuries
- [FINANCE] ESS adds 8.5 GWh of sodium-ion to its battery storage portfolio
- [FINANCE] Trump tariff refunds start hitting importers’ bank accounts - MSN
- [FINANCE] Earnings call transcript: Sera Prognostics Q1 2026 revenue plummets
- [FINANCE] Earnings call transcript: Array Technologies Q1 2026: Profitability Soars Amid Revenue Growth
- [FINANCE] Earnings call transcript: Purecycle Technologies Q1 2026 earnings beat EPS but miss revenue